INTECH Investment Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.47M Sell
9,819
-21,680
-69% -$2.36M 0.01% 843
2026
Q1
$2.91M Sell
31,499
-16,784
-35% -$1.69M 0.03% 540
2025
Q4
$4.93M Sell
48,283
-2,700
-5% -$242K 0.04% 381
2025
Q3
$3.19M Sell
50,983
-11,458
-18% -$623K 0.03% 544
2025
Q2
$3.25M Buy
62,441
+2,254
+4% +$101K 0.03% 508
2025
Q1
$2.56M Buy
60,187
+16,363
+37% +$706K 0.03% 621
2024
Q4
$1.34M Buy
43,824
+10,976
+33% +$309K 0.01% 956
2024
Q3
$754K Buy
+32,848
New +$930K 0.01% 977

Other funds holding GH

INTECH Investment Management's GH Position: Q2 2026 in Review

INTECH Investment Management reduced its Guardant Health (GH) stake by 69% in Q2 2026, selling an estimated $2.36M and leaving 9,819 shares worth $1.47M. The position accounts for 0.01% of the portfolio, ranked #843.

INTECH Investment Management first reported a position in GH in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.93M in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • INTECH Investment Management held 9,819 shares of Guardant Health worth $1.47M as of Q2 2026.
  • INTECH Investment Management sold 21,680 Guardant Health shares in Q2 2026, an estimated $2.36M.
  • Guardant Health made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #843 holding.
  • INTECH Investment Management first reported a position in Guardant Health in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Guardant Health position peaked at $4.93M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.